Eutilex Co.,Ltd.
Develops immunotherapeutics for cancers and autoimmune diseases via T-cell/antibody tech.
263050 | KO
Overview
Corporate Details
- ISIN(s):
- KR7263050007
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 금천구 가산디지털1로 58 408호 (가산동, 에이스한솔타워), 서울특별시
- Website:
- https://www.eutilex.com/en/
- Sector:
- Manufacturing
Description
Eutilex Co., Ltd. is a biotechnology company focused on the research and development of immunotherapeutics for cancers and autoimmune diseases. The company's core approach involves selecting targets that enhance or suppress human immune responses. Its pipeline is centered on three primary technology platforms: T-cell therapy, antibody therapy, and CAR-T cell therapy. Key development programs include adoptive T-cell therapies, such as those based on 4-1BB cytotoxic T lymphocytes (CTL), and various immunomodulatory antibody therapeutics designed to treat a range of incurable diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-14 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2022-09-01 00:00 |
투자판단관련주요경영사항( EU307(GPC3-IL18 CAR-T치료제) 간세포암 대상 제1 상 임상시험계획서 신청)
|
Korean | 8.7 KB | ||
| 2022-08-16 00:00 |
기타경영사항(자율공시)(CAR-T치료제 EU301(MVR CAR-T) 러시아 특허권 취득)
|
Korean | 6.9 KB | ||
| 2022-08-16 00:00 |
[기재정정]사업보고서 (2021.12)
|
Korean | 832.7 KB | ||
| 2022-08-16 00:00 |
[기재정정]사업보고서 (2021.12)
|
Korean | 1.5 MB | ||
| 2022-08-16 00:00 |
반기보고서 (2022.06)
|
Korean | 1.2 MB | ||
| 2022-08-05 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 15.3 KB | ||
| 2022-08-03 00:00 |
기타경영사항(자율공시)(항 4-1BB 항체치료제 EU101 러시아 특허권 취득(분할특허))
|
Korean | 6.8 KB | ||
| 2022-07-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2022-07-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2022-07-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2022-07-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.8 KB | ||
| 2022-07-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2022-07-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2022-07-27 00:00 |
기타경영사항(자율공시)(항 4-1BB 항체치료제 EU101 국내 특허권 취득(분할특허))
|
Korean | 6.4 KB |
Automate Your Workflow. Get a real-time feed of all Eutilex Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Eutilex Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Eutilex Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
